title: Intravitreal aflibercept injection and photodynamic treatment of a patient with unilateral subretinal neovascular membrane associated with fundus flavimaculatus.
abstract: We report the good outcome of combined intravitreal aflibercept injection and photodynamic treatment in a case with fundus flavimaculatus (FFM) and unilateral subretinal neovascular membrane (SRNM). A 57-year-old man with FFM and unilateral SRNM who was treated with two consecutive ranibizumab injections with no improvement at another institution was referred to us. He was treated successfully with three aflibercept injections three months apart and a single photodynamic treatment performed a week after the initial aflibercept injection. Six weeks after the last aflibercept injection visual acuity was improved and submacular exudation exhibited dramatic resolution with a moderate degree of residual scarring. SRNM formation is rarely observed in eyes with FFM and a satisfactory outcome can be achieved with a proper treatment.
authors.affiliation: Department of Ophthalmology, Dokuz Eylül University, 35340 Izmir, Turkey.
authors.forename: Ali Osman
authors.identifier: 0000-0001-6848-7239
authors.initials: AO
authors.lastname: Saatci
authors.affiliation: Department of Ophthalmology, Dokuz Eylül University, 35340 Izmir, Turkey.
authors.forename: Ziya
authors.initials: Z
authors.lastname: Ayhan
authors.affiliation: Bozyaka Education and Research Hospital, 35170 Izmir, Turkey.
authors.forename: Bora
authors.identifier: 0000-0001-5998-9122
authors.initials: B
authors.lastname: Yüksel
authors.affiliation: Department of Ophthalmology, Celal Bayar University, 45030 Manisa, Turkey.
authors.forename: Göktuğ
authors.initials: G
authors.lastname: Seymenoğlu
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, IL 60637, USA.
authors.forename: Seenu M
authors.initials: SM
authors.lastname: Hariprasad
references.citation: Ann Ophthalmol. 1982 Apr;14(4):331-4
references.pmid: 6179449
references.citation: Arq Bras Oftalmol. 2005 Mar-Apr;68(2):263-5
references.pmid: 15905953
references.citation: Klin Monbl Augenheilkd. 2007 Apr;224(4):353-5
references.pmid: 17458813
references.citation: Graefes Arch Clin Exp Ophthalmol. 1992;230(5):498-500
references.pmid: 1521820
references.citation: Am J Ophthalmol. 2005 Aug;140(2):312-4
references.pmid: 16086955
references.citation: Trans Am Ophthalmol Soc. 1986;84:453-87
references.pmid: 3590477
references.citation: Ophthalmology. 2014 Jan;121(1):188-92
references.pmid: 24144450
references.citation: Retin Cases Brief Rep. 2008 Summer;2(3):250-2
references.pmid: 25390102
references.citation: Ophthalmology. 1998 Mar;105(3):448-57; discussion 457-8
references.pmid: 9499775
references.citation: J Fr Ophtalmol. 2006 Feb;29(2):188-94
references.pmid: 16523163
references.citation: Ophthalmology. 2014 Jan;121(1):193-201
references.pmid: 24084500
references.citation: Ophthalmic Res. 2009;42(3):152-4
references.pmid: 19628956
references.citation: Eye (Lond). 2014 Jul;28(7):895-9
references.pmid: 24833178
references.citation: Arch Ophtalmol Rev Gen Ophtalmol. 1965 Sep;25(6):505-30
references.pmid: 4221555
references.citation: Arch Ophthalmol. 1978 Nov;96(11):2054-7
references.pmid: 718494
references.citation: Can J Ophthalmol. 2012 Jun;47(3):e3-5
references.pmid: 22687319
references.citation: Retina. 2002 Feb;22(1):111-3
references.pmid: 11884891
references.citation: Br J Ophthalmol. 2014 Jun;98 Suppl 1:i22-27
references.pmid: 24836866